Startseite>>Signaling Pathways>> Tyrosine Kinase>> Spleen Tyrosine Kinase (Syk)>>Cevidoplenib dimesylate

Cevidoplenib dimesylate (Synonyms: SKI-O-703 dimesylate)

Katalog-Nr.GC63455

Cevidoplenib ist ein oral verfÜgbarer Inhibitor der Milz-Tyrosinkinase (Syk) mit potenziell entzÜndungshemmenden und immunmodulierenden AktivitÄten.

Products are for research use only. Not for human use. We do not sell to patients.

Cevidoplenib dimesylate Chemische Struktur

Cas No.: 2043659-93-2

Größe Preis Lagerbestand Menge
10m (in 1mL DMSO)
293,00 $
Auf Lager
5mg
266,00 $
Auf Lager
10mg
420,00 $
Auf Lager
25mg
805,00 $
Auf Lager
50mg
1.260,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase (Syk), with potential anti-inflammatory and immunomodulating activities[1][2].

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 31, No. 4, 2017.
[2]. cevidoplenib dimesylate.

Bewertungen

Review for Cevidoplenib dimesylate

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cevidoplenib dimesylate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.